跳至主要内容
临床试验/ITMCTR1900002842
ITMCTR1900002842尚未招募1 期

Prospective, randomized, double-blind, controlled, multi-center clinical study for Hushen Yiqi Granule in the treatment of IgA nephropathy

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. Pathological diagnosis of patients with IgA nephropathy;
  • 2. 24-hour urine protein quantitation >= 1.0g (two tests, interval > 7 days), or CKD 2-4;
  • 3. Aged 18-80 years;
  • 4. Sign the informed consent form.

排除标准

  • 1. Combine life-threatening complications such as severe infections, new malignant tumors, severe water-electrolyte disorders, severe heart, brain, liver, hematopoietic system, and gastrointestinal tract such as vital organ diseases or dysfunctions;
  • 2. Those who are known to be allergic to the drugs used;
  • 3. Patients with mental illness;
  • 4. Pregnant or lactating women;
  • 5. Being accepted by other clinical trials;
  • 6. Patients with secondary IgA nephropathy;
  • 7. Patients with IgA nephropathy who present with progressive nephritis;
  • 8. Other persons who have no capacity for civil conduct and limit their capacity for civil conduct.

研究者

发起方
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

相似试验

已完成
4 期
Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgery'Hypovolaemia' + 'Decreased blood volume'10014412
NL-OMON53031PRA Belgium BV350
进行中(未招募)
1 期
Prospective, randomized, controlled, double-blind, multi-centre,multinational study on the safety and efficacy of 6% Hydroxyethyl starch(HES) solution versus an electrolyte solution in patients undergoingelective abdominal surgery-PHOENICS
EUCTR2016-002162-30-ROFresenius Kabi Deutschland GmbH2,280
进行中(未招募)
1 期
Controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgeryHypovolaemia due to acute blood loss in elective abdominal surgeryMedDRA version: 19.1Level: PTClassification code 10021137Term: HypovolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-002162-30-ESB. Braun Melsungen AG2,280
进行中(未招募)
1 期
Controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgeryHypovolaemia due to acute blood loss in elective abdominal surgeryMedDRA version: 20.0Level: PTClassification code 10021137Term: HypovolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-002162-30-NLFresenius Kabi Deutschland GmbH2,280
进行中(未招募)
不适用
Trial with two lipid emulsions already approved for artificial nutrition to evaluate possible differences in the efficacy and safety of a fish oil containing lipid emulsion versus a standard soybean oil-based lipid emulsion in patients with Acute Lung InjuryAcute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspirationMedDRA version: 16.1Level: PTClassification code 10069351Term: Acute lung injurySystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-003397-82-DEB. Braun Melsungen AG